Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma ; volume:38 ; number:12 ; day:16 ; month:9 ; year:2024 ; pages:2663-2674 ; date:12.2024
Leukemia ; 38, Heft 12 (16.9.2024), 2663-2674, 12.2024

Creator
Willis, Brandon S.
Mongeon, Kevin
Dry, Hannah
Neveras, India L.
Bryan, Nadezda
Pandya, Meghana
Roderick-Richardson, Justine
Xu, Wendan
Yang, Li
Rosen, Alan
Reimer, Corinne
Tuskova, Liliana
Klener, Pavel
Mettetal, Jerome T.
Lenz, Georg
Barry, Simon T.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41375-024-02401-9
URN
urn:nbn:de:101:1-2502102141116.476635358386
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Willis, Brandon S.
  • Mongeon, Kevin
  • Dry, Hannah
  • Neveras, India L.
  • Bryan, Nadezda
  • Pandya, Meghana
  • Roderick-Richardson, Justine
  • Xu, Wendan
  • Yang, Li
  • Rosen, Alan
  • Reimer, Corinne
  • Tuskova, Liliana
  • Klener, Pavel
  • Mettetal, Jerome T.
  • Lenz, Georg
  • Barry, Simon T.
  • SpringerLink (Online service)

Other Objects (12)